Freedom Leaf
OCTOBER 15, 2018
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.
Cannabis Law Report
SEPTEMBER 23, 2019
27 There is moderate evidence for the use of cannabinoids for sleep and limited evidence for use in psychiatric conditions, such as post-traumatic stress disorder, depression, anxiety, and psychosis; appetite stimulation and weight gain; and no evidence for cancer treatment. Moderate evidence exists for the use of cannabis for sleep.
The Cannigma
FEBRUARY 16, 2022
CP: Catalog, like a magazine? Is this as needed for sleep? They’re college athletes, or they’re not sleeping, their bodies aren’t recovering. And proficiency testing right now, because of the DEA is very limited in what can get sent out. And I realized that that “as needed”, was very subjective, right?
Expert insights. Personalized for you.
51 
Let's personalize your content